胆酶α调节了与自相关的外体释放,以促进质瘤细胞的进展
Jialin Li1, Yang Zhao1, Xiao Wu1
1School of Clinical Medicine, Ningxia Medical University, Yinchuan, China.
Biochemical and biophysical research communications
|January 8, 2025
概括
胆激酶α (CHKA) 通过自调节增加外生体释放来促进质瘤的进展. 这项研究揭示了CHKA作为质瘤病原和外体细胞分泌的一个关键因素.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 质瘤是一种常见的成年大脑瘤,预后不佳.
- 来自瘤的外体是癌症进展的关键调解者.
- 胆激酶α (CHKA) 在质瘤和外体细胞分泌中的作用尚不清楚.
研究的目的:
- 研究CHKA在质瘤细胞增殖,迁移和入侵中的作用.
- 阐明CHKA通过哪种机制影响质瘤中的外分泌物.
- 确定CHKA调节的外体对质瘤进展的影响.
主要方法:
- 评估了质瘤细胞的增殖,迁移和入侵.
- 在不同的CHKA表达水平下量化外体释放.
- 研究了自在CHKA介导的外体分泌中的作用.
- 分析了CHKA操纵的质瘤细胞外体的生物效应.
主要成果:
- CHKA显著增强了质瘤细胞的增殖,迁移和入侵.
- CHKA可以提高质瘤细胞对外分泌的调节.
- 减少CHKA表达增加了自,抑制了外体释放;阻断自恢复了分泌.
- 来自CHKA表达细胞的外基因组在促进质瘤进展方面更为有效.
结论:
- 通过增强外体细胞分泌,CHKA促进质瘤的进展.
- 通过一种自取决于自的途径,CHKA调节外体分泌.
- 通过影响外体细胞介导瘤生长,CHKA是质瘤治疗的潜在治疗标.
更多相关视频
06:58Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
575
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
9.6K
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Delivery Pathways to the Lysosome
6.1K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.1K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
